Lv11
60 积分 2026-05-20 加入
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
1小时前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
1小时前
已完结
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
2小时前
已完结
Efficacy and Safety of Cagrilintide and Cagrisema Versus Semaglutide as Anti‐Obesity Medications: A Systematic Review, Meta‐Analysis and Meta‐Regression
28天前
已完结
Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis
2个月前
已完结
Brain Amylin Signaling, Feeding, and Reward
4个月前
已完结
The story of amylin: from physiology to therapy
4个月前
已完结
皖公网安备34019202002308
